Akin Advises Pharmakon Advisors in its $250 Million Debt Financing for Geron Corporation
Contact:
(New York) – Akin advised Pharmakon Advisors, LP and its investment funds in providing Geron Corporation, a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, with $250 million of committed senior secured debt financing, alongside a $125 million synthetic royalty with Royalty Pharma, to support the commercial launch of RYTELO™ in the U.S.
The Akin team was led by tax partner Geoffrey Secol and included senior counsel Miriam Foley and associates Jake Gawlak and Joseph Lordi. Additional support was provided by tax partner David Snyder; international trade partner Nnedinma Ifudu Nweke; senior counsel Jo-Ellyn Klein; counsel Ekaterina Lyashenko; and associates Caroline Kessler and John Kwack.
Further information on the transaction can be found here.
Akin is a leading international law firm with more than 900 lawyers in offices throughout the United States, Europe, Asia and the Middle East.
# # #
People Mentioned in This News
